Corline Biomedical AB (STO:CLBIO)
Sweden
· Delayed Price · Currency is SEK 10.00
-0.40 (-3.85%)
May 15, 2025, 4:36 PM CET
Corline Biomedical AB Revenue
Corline Biomedical AB had revenue of 2.23M SEK in the quarter ending March 31, 2025, a decrease of -59.99%. This brings the company's revenue in the last twelve months to 13.86M, down -55.23% year-over-year. In the year 2024, Corline Biomedical AB had annual revenue of 17.27M, down -51.37%.
Revenue (ttm)
13.86M
Revenue Growth
-55.23%
P/S Ratio
18.38
Revenue / Employee
1.07M
Employees
13
Market Cap
254.70M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 17.27M | -18.25M | -51.37% |
| Dec 31, 2023 | 35.52M | 2.93M | 8.98% |
| Dec 31, 2022 | 32.59M | 15.40M | 89.55% |
| Dec 31, 2021 | 17.19M | 2.12M | 14.05% |
| Dec 31, 2020 | 15.08M | 3.15M | 26.44% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.24B |
| Sectra AB | 3.30B |
| Getinge AB | 35.57B |
| Medicover AB | 23.56B |
| Camurus AB | 1.87B |
| AddLife AB | 10.42B |
| Vitrolife AB | 3.61B |
| Vimian Group AB | 4.24B |